Dermatan sulfate: Difference between revisions
No edit summary |
Rabin Bista (talk | contribs) No edit summary |
||
Line 1: | Line 1: | ||
{{Drugbox | |||
| Verifiedfields = changed | |||
| Watchedfields = changed | |||
| verifiedrevid = 447549315 | |||
| image = Dermatan Wiki Str.png | |||
<!--Clinical data--> | |||
| tradename = | |||
| Drugs.com = {{drugs.com|international|dermatan-sulfate}} | |||
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X --> | |||
| pregnancy_US = <!-- A / B / C / D / X --> | |||
| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled--> | |||
| legal_CA = <!-- Schedule I, II, III, IV, V, VI, VII, VIII --> | |||
| legal_UK = <!-- GSL, P, POM, CD, or Class A, B, C --> | |||
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V --> | |||
<!--Identifiers--> | |||
| CASNo_Ref = {{cascite|correct|CAS}} | |||
| CAS_number_Ref = {{cascite|correct|??}} | |||
| CAS_number = 24967-94-0 | |||
| ATC_prefix = B01 | |||
| ATC_suffix = AX04 | |||
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} | |||
| ChemSpiderID = 30361 | |||
<!--Chemical data--> | |||
| C = 14 |H = 21 |N = 1 |O = 15 |S = 2 | |||
| molecular_weight = | |||
| smiles = [O-]C(=O)[C@@H]2O[C@@H](O[C@H]1[C@@H](OS([O-])(=O)=O)[C@H](O[C@@H](O)[C@@H]1NC(=O)C)CO)[C@H](O)[C@@H](O)[C@@H]2O | |||
| InChI = 1/C14H23NO15S/c1-3(17)15-5-10(9(30-31(24,25)26)4(2-16)27-13(5)23)28-14-8(20)6(18)7(19)11(29-14)12(21)22/h4-11,13-14,16,18-20,23H,2H2,1H3,(H,15,17)(H,21,22)(H,24,25,26)/p-2/t4-,5-,6+,7+,8-,9+,10-,11-,13-,14-/m1/s1 | |||
| InChIKey = AVJBPWGFOQAPRH-SRMSFAINBD | |||
| ChEMBL_Ref = {{ebicite|changed|EBI}} | |||
| ChEMBL = 1909290 | |||
| StdInChI_Ref = {{stdinchicite|correct|chemspider}} | |||
| StdInChI = 1S/C14H23NO15S/c1-3(17)15-5-10(9(30-31(24,25)26)4(2-16)27-13(5)23)28-14-8(20)6(18)7(19)11(29-14)12(21)22/h4-11,13-14,16,18-20,23H,2H2,1H3,(H,15,17)(H,21,22)(H,24,25,26)/p-2/t4-,5-,6+,7+,8-,9+,10-,11-,13-,14-/m1/s1 | |||
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}} | |||
| StdInChIKey = AVJBPWGFOQAPRH-FWMKGIEWSA-L | |||
}} | |||
__NOTOC__ | __NOTOC__ | ||
{{SI}} | {{SI}} | ||
Line 29: | Line 70: | ||
{{Glycosaminoglycans}} | {{Glycosaminoglycans}} | ||
[[Category:drug]] | |||
[[Category:Glycosaminoglycans]] | [[Category:Glycosaminoglycans]] |
Latest revision as of 16:03, 14 April 2015
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
ATC code | |
Identifiers | |
CAS Number | |
ChemSpider | |
ChEMBL | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | C14H21NO15S2 |
Molar mass | 507.43 g·mol−1 |
3D model (JSmol) | |
| |
| |
(what is this?) (verify) |
WikiDoc Resources for Dermatan sulfate |
Articles |
---|
Most recent articles on Dermatan sulfate Most cited articles on Dermatan sulfate |
Media |
Powerpoint slides on Dermatan sulfate |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Dermatan sulfate at Clinical Trials.gov Trial results on Dermatan sulfate Clinical Trials on Dermatan sulfate at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Dermatan sulfate NICE Guidance on Dermatan sulfate
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Dermatan sulfate Discussion groups on Dermatan sulfate Patient Handouts on Dermatan sulfate Directions to Hospitals Treating Dermatan sulfate Risk calculators and risk factors for Dermatan sulfate
|
Healthcare Provider Resources |
Causes & Risk Factors for Dermatan sulfate |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Dermatan sulfate is a glycosaminoglycan (formerly called a mucopolysaccharide) found mostly in skin, but also in blood vessels, heart valves, tendons, and lungs.
It is also referred to as chondroitin sulfate B, [1] although it is no longer classified as a form of chondroitin sulfate by most sources.
Function
Dermatan sulfate may have roles in coagulation, cardiovascular disease, carcinogenesis, infection, wound repair, and fibrosis.
Pathology
Dermatan sulfate accumulates abnormally in several of the mucopolysaccharidosis disorders.
An excess of Dermatan Sulfate in the Mitral Valve is characteristic of myxomatous degeneration of the leaflets leading to redundancy of valve tissue and ultimately, Mitral Valve Prolapse (into the Left Ventricle) and insufficiency. This chronic prolapse occurs mainly in women over the age of 60, and can predispose the patient to mitral annular calcification and eccentric (volume dependent or dilated) hypertrophy and eventually Left Heart failure if untreated. Also used to treat sun burns.
See Also
External Links
- B01AX04 (WHO)
- Dermatan+sulfate at the US National Library of Medicine Medical Subject Headings (MeSH)
References
- Pages with script errors
- Pages with citations using unsupported parameters
- CS1 errors: dates
- Template:drugs.com link with non-standard subpage
- Articles with changed EBI identifier
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Chemical articles with unknown parameter in Infobox drug
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without UNII source
- Drugs with no legal status
- Drugboxes which contain changes to verified fields
- Drugboxes which contain changes to watched fields
- Drug
- Glycosaminoglycans